Optima Chemical appoints Terry Rathman as consultant

A leading authority on lithium chemistry

Dr Terry Rathman has joined US-based Optima Chemical, as a consultant.

Rathman has a reputation as ‘Mr Lithium’, emphasising his industry status as the foremost authority on lithium chemistry, according to Gene Williams, president of Optima Chemical.

‘He is the ideal addition to our organisation, which now offers lithium products such as alkyllithiums, aryllithiums, lithium amides and lithium alkoxides, resulting from our recent acquisition and licensing of selected products from FMC Lithium,’ he said.

‘I am eager to collaborate with my new colleagues, looking forward to assisting them in promoting lithium products that include and highlight those targeted to sophisticated pharmaceutical applications,’ added Rathman.

Rathman is sole proprietor of t-Links Consulting, based in Gastonia, North Carolina. Since 2002, Rathman has been a technical consultant to Calvert Holdings, Chiral Technologies, PetroCrystals and Honeywell Pharmaceutical Fine Chemical Division.

Before establishing his own consultancy, Rathman was in charge of Organic Technical Development at FMC Lithium, advancing from his prior FMC assignments as senior technologist and earlier on, as a bench chemist.

You may also like

Manufacturing

Optima chemical to capitalise on acquisition of lithium product lines

Following its December agreement with Lithium FMC to purchase and license selected lithium products, US custom research and manufacturing company Optima Chemical has launched a range of inorganometallic products under its own brand.
Ingredients

Safe and accurate flow measurement for pharmaceutical production

Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity solvents to more viscous pharmaceutical ingredients
Manufacturing

NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain

NorthStar Medical Radioisotopes and QSA Global have announced a new strategic services agreement to support commercial-scale production of actinium-225 through a closed-loop radium-226 target supply and recycling programme for targeted alpha therapies
Ingredients

Pioneering AAV approach unlocks cause of rheumatoid arthritis pain

Karolinska Institute researchers use AAV products to uncover neural mechanisms behind rheumatoid arthritis pain
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge

A new Moody's report identifies four compounding risk factors driving pharmaceutical supply chain instability and warns that siloed risk management is leaving the sector dangerously exposed
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing

As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
Ingredients

The impact of Brexit on raw materials testing for the pharmaceutical industry (2026 update)

Since the UK departed from the EU, the pharmaceutical regulatory landscape has undergone significant and lasting change; whereas early uncertainty has largely subsided, the system has evolved into a stable but more complex dual framework
Subscribe now